CLINICAL_TRIALS ClinicalTrials.gov record update

The Role of Serum Adropin, Salusin-α, Netrin-1, and Nesfatin-1 in Endometrioma and Their Association With Insulin Resistance

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04371133
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:43.495658+00:00
Published At: 2020-05-01T00:00:00+00:00
Record Updated At: 2020-05-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Endometrioma", "Inflammation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-05-01"
protocolSection.identificationModule.nctId: "NCT04371133"
protocolSection.identificationModule.officialTitle: "The Role of Serum Adropin, Salusin-\u03b1, Netrin-1, and Nesfatin-1 in Endometrioma and Their Association With Insulin Resistance"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.